Abbott Laboratories (NYSE: ABT) more or less met analyst estimates in its first quarter, the results of which were published ...
Shares of Abbott Laboratories (NYSE:ABT) fell 3.2% on Thursday morning after the healthcare conglomerate marginally beat Wall ...
Investor's Business Daily on MSN
Abbott Laboratories slammed on its post-Exact Sciences guidance
Abbott stock took a hit early Thursday on lackluster guidance for the year and second quarter following the takeover of Exact ...
Abbott Laboratories (NYSE:ABT) reported first-quarter 2026 results that management said were “aligned with our expectations ...
Abbott Laboratories ABT on Thursday posted upbeat first-quarter earnings but revised its 2026 earnings outlook below ...
Abbott Laboratories cut its full-year earnings outlook to account for a recent acquisition and said its nutrition unit continued to notch soft sales during the first quarter. The company, which sells ...
Abbott (ABT) stock dips as the company trims 2026 EPS guidance to reflect its recent $21B acquisition of Exact Sciences. Read ...
Abbott (ABT) stock fell 4.3% despite beating Q1 revenue estimates. Margin compression and reduced guidance triggered the ...
Abbott Laboratories won the dismissal of a proposed class action by parents who alleged its Similac infant formula contained ...
A Cook County jury found the Lake County company's cow-milk-based infant formula contributed to a life-threatening condition ...
Abbott (ABT) drops 4.5% after earnings and lowered 2026 EPS guidance; see top healthcare ETFs with big ABT exposure and ...
A Chicago jury has ordered Abbott Laboratories to pay $53 million in compensatory damages to four families who claimed the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results